OMEICOS Therapeutics GmbH
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.omeicos.com
Clinical Trials
11
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Omeicos Therapeutics GmbH
- Target Recruit Count
- 32
- Registration Number
- NCT05972954
- Locations
- 🇩🇪
Universitätsklinikum Bonn, Sektion Neuromuskuläre Erkrankungen, Klinik und Poliklinik für Neurologie, Venusberg-Campus 1, Gebäude 80, NPP, Bonn, Germany
🇩🇪Medizinisch Fakultät der Martin-Luther-Universität Halle-Wittenberg Universitätsklinik und Poliklinik für Neurologie Universitätsklinikum , Ernst-Grube-Str. 40, Halle, Germany
🇩🇪Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik, Klinikum der Universität München, Ludwig-Maximilians-Universität (LMU Klinikum), Ziemssenstr. 1a, Munich, Germany
Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF)
- First Posted Date
- 2019-04-08
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Omeicos Therapeutics GmbH
- Target Recruit Count
- 136
- Registration Number
- NCT03906799
- Locations
- 🇧🇬
Site 401, Sofia, Bulgaria
🇧🇬Site 404, Stara Zagora, Bulgaria
🇧🇬Site 402, Varna, Bulgaria
Safety and Pharmacokinetic Study of OMT-28 in Healthy Subjects
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2018-09-28
- Lead Sponsor
- Omeicos Therapeutics GmbH
- Target Recruit Count
- 75
- Registration Number
- NCT03078738
- Locations
- 🇩🇪
CRS-Mönchengladbach, Monchengladbach, Germany